The effectiveness of drug abuse treatment: implications for controlling AIDS/HIV infection
Office of Technology Assessment
Record ID 31995000077
To examine evidence on the effectiveness of drug abuse treatment, to evaluate its potential role in reducing the spread of HIV, and to compare it to other approaches to HIV prevention among this high-risk group.
Authors' results and conclusions: Methadone maintenance is clearly efficacious in reducing opiate use and associated IV use of heroin. Its effectiveness, however, may sometimes be compromised by inadequate doses of methadone. Philosophical and political differences about the use of methadone, such as concerns about substituting one opiate for another and fears of illegal diversion, have inhibited administration of adequate does. As a result, methadone's potential to prevent HIV is probably not be realized. No clearly efficacious treatment for cocaine, whose use in IV and smokable forms is associated with HIV transmission, is yet available. Interpretation of studies to evaluation residential therapeutic communities (TCs) and outpatient drug-free (ODF) programs is more difficult because of a lack of external control groups.
Authors' recomendations: Preventing further spread of HIV increases the pressure for re-examination and scientific evaluation of public policies regarding the availability of syringes and needles. Temporarily providing methadone and counselling, without the additional ancillary services ordinarily part of methadone maintenance, to IV opiate users who are on waiting lists for treatment merits strong consideration. The impact of incremental, even partial, but sustained reductions due to methadone maintenance and perhaps other drug treatment approaches can be substantial in breaking the chain of HIV transmission.
Authors' methods: Review
Project Status: Completed
URL for project: http://www.wws.princeton.edu:80/~ota/ns20/pubs_f.html
Year Published: 1990
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
- Acquired Immunodeficiency Syndrome
- HIV Infections
- Substance Abuse Treatment Centers
- Substance-Related Disorders
Organisation Name: U. S. Congress. Office of Technology Assessment
Copyright: Office of Technology Assessment
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.